How long does drug-resistant epilepsy treatment take? Planning medication, procedures, and withdrawal

The length of a hospital admission and the duration of epilepsy treatment answer different questions. An admission may complete one investigation or procedure while medication adjustment and observation continue for much longer. Drug-resistant epilepsy has no single treatment course that applies to everyone. A practical schedule identifies the decision at each stage, the evidence needed to make it, and the clinician responsible for follow-up. This article uses guidance and research checked through September 9, 2026 to explain how patients can discuss that schedule. NICE NG217: Terms used, drug-resistant epilepsy definition, updated January 2025NICE NG217: Principles of treatment, safety, monitoring and withdrawal

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Drug resistance is assessed from unsuccessful adequate trials of two appropriately chosen, tolerated, and properly used antiseizure medication schedules that have not achieved sustained seizure freedom. Years since diagnosis alone do not establish it. Conversely, a long history of treatment may still require a careful review of the diagnosis, actual use, and adequacy of previous trials. ILAE: Drug-Resistant Epilepsy, definition and clinical resources
A multicenter observational study published in 2026 included 964 adults who had undergone resective epilepsy surgery and were seizure-free before medication withdrawal. Starting withdrawal within the first two postoperative years was associated with a higher initial relapse risk than later withdrawal. Longer-term outcomes were not substantially associated with starting time. This compared clinical groups; it did not randomly assign every patient to a fixed withdrawal schedule. Ferreira-Atuesta et al.: Timing of antiseizure medication withdrawal after adult epilepsy surgery, multicenter observational study, Neurology 2026
Employment, examinations, family care, and visa limits are genuine constraints. Share them early. Some steps may be rearranged, while necessary medical observation cannot always be shortened safely. A new seizure, infection, or adverse reaction may change the return journey and should have a practical contingency plan.

Quick answer

The length of a hospital admission and the duration of epilepsy treatment answer different questions. An admission may complete one investigation or procedure while medication adjustment and observation continue for much longer. Drug-resistant epilepsy has no single treatment course that applies to everyone. A practical schedule identifies the decision at each stage, the evidence needed to make it, and the clinician responsible for follow-up. This article uses guidance and research checked through September 9, 2026 to explain how patients can discuss that schedule. NICE NG217: Terms used, drug-resistant epilepsy definition, updated January 2025 NICE NG217: Principles of treatment, safety, monitoring and withdrawal

Full guide

The length of a hospital admission and the duration of epilepsy treatment answer different questions. An admission may complete one investigation or procedure while medication adjustment and observation continue for much longer. Drug-resistant epilepsy has no single treatment course that applies to everyone. A practical schedule identifies the decision at each stage, the evidence needed to make it, and the clinician responsible for follow-up. This article uses guidance and research checked through September 9, 2026 to explain how patients can discuss that schedule. NICE NG217: Terms used, drug-resistant epilepsy definition, updated January 2025 NICE NG217: Principles of treatment, safety, monitoring and withdrawal

Drug resistance does not require waiting a fixed number of years

Drug resistance is assessed from unsuccessful adequate trials of two appropriately chosen, tolerated, and properly used antiseizure medication schedules that have not achieved sustained seizure freedom. Years since diagnosis alone do not establish it. Conversely, a long history of treatment may still require a careful review of the diagnosis, actual use, and adequacy of previous trials. ILAE: Drug-Resistant Epilepsy, definition and clinical resources

Once drug resistance is established, specialist evaluation should proceed promptly. Medication optimization can continue while a surgical evaluation is arranged. Referral is an opportunity to assess options and does not commit the patient to an operation. A blanket instruction to wait several more years can postpone useful assessment for someone who already meets referral criteria. Jehi et al.: Timing of referral for epilepsy surgery evaluation, ILAE consensus, 2022

For the patient, the immediate question is often whether existing records are sufficient to make that judgment. A concise history of previous drugs, responses, and reasons for stopping can be more helpful than a long list of prescriptions without dates or outcomes.

Connect each appointment to a decision

A useful stage plan names the outstanding question: whether the events are epileptic, whether the seizure origin can be localized, whether the current combination is tolerable, or whether a procedure is appropriate. It then identifies the examination, record, or observation needed to answer it. An estimated date is helpful when accompanied by the factors that might change it.

If video-EEG does not record the relevant event, the next step is not necessarily a longer admission. The team may review the information already available, reconsider the monitoring strategy, or select another investigation. If imaging and electrical findings conflict, additional evidence may be needed before a treatment decision is safe.

Patients can ask for a short written account of the current stage. This makes a delay easier to understand and reduces the chance that tests are repeated simply because the reason for the previous investigation is unclear. It also helps a local clinician continue the process if the patient cannot remain near the specialist center.

Titration and assessment of benefit are different periods

Some medicines must be introduced gradually to manage tolerability and safety. Lack of ideal control during the initial steps does not necessarily mean that an adequate treatment trial has been completed. Cenobamate, for example, has specific titration and safety requirements. A planned journey, examination, or work deadline is not a reason to accelerate the schedule independently. DailyMed: XCOPRI U.S. prescribing information, revised August 2025, current retrieval September 2026

The specialist considers seizure frequency and severity, actual medication use, the treatment intensity reached, and adverse effects when judging the trial. A person whose seizures occur frequently provides a different observation pattern from someone whose events were already separated by several months. A short period without seizures is encouraging information, but cannot alone establish that long-term risk has disappeared.

Ask what will count as a reason to continue, modify, or stop the trial under supervision. This is more informative than asking for a universal number of weeks after which every drug must have worked. A planned review also allows practical problems, such as difficulty obtaining the prescribed formulation, to be addressed before they disrupt treatment.

Review dates are not instructions to ignore problems until then

If the person becomes too sleepy to attend school or repeatedly falls, contact the team before the planned review. Severe skin symptoms, major changes in awareness, or another medical emergency require immediate assessment. An observation period is intended to collect useful information while maintaining safety, not to require endurance of serious harm. NICE NG217: Principles of treatment, safety, monitoring and withdrawal

Positive changes beyond seizure frequency also belong in the record. Better sleep, clearer thinking, improved mood, and greater independence may affect the decision to continue a treatment. Research published in 2026 again connects quality of life in adults with drug-resistant focal epilepsy with seizure and depression-related factors. Time spent evaluating a therapy should therefore include the outcomes that matter in the patient's life. Mula et al.: Drug-treatment changes, depression and quality of life in adult drug-resistant focal epilepsy, Epilepsia July 2026

At each review, the team can identify which observations remain uncertain and whether more time is likely to answer them. Repeating an unchanged prescription without explaining that purpose can leave patients unsure whether there is an active plan.

Presurgical assessment takes as long as the unresolved questions require

The schedule depends on whether previous imaging is adequate, whether epilepsy-specific MRI is needed, whether typical seizures can be recorded, and whether language and memory assessments are complete. Some patients have a consistent set of findings early. Others need more discussion or investigation. A visible lesion does not by itself justify promising an operation within a few days. Bernasconi et al.: ILAE structural MRI recommendations and HARNESS protocol, 2019 Baxendale et al.: ILAE neuropsychological assessment in epilepsy surgery, 2019

During an inpatient video-EEG admission, clinicians may adjust medication to help record events. That occurs within a monitored diagnostic setting with arrangements for managing seizures. It is not a model for reducing treatment at home. A 2026 study of tapering in epilepsy monitoring units highlights the need to balance diagnostic yield with patient risk and the absence of one universally standardized protocol. Nix et al.: Optimizing antiseizure medication taper in the epilepsy monitoring unit, Neurology Clinical Practice 2026

When arranging travel to a specialist center, ask which parts of the evaluation can use existing records and which require attendance. Confirm whether a multidisciplinary decision can be made before discharge or whether a later meeting and follow-up discussion will be necessary.

Surgical recovery and assessment of seizure outcome run on different schedules

Discharge instructions should distinguish wound review, pathology or imaging review, seizure follow-up, and functional recovery. Being well enough to leave hospital does not automatically mean being ready for every work task, independent travel, or medication withdrawal. Fatigue, memory, language, and mood may need evaluation against the preoperative baseline. Oxford University Hospitals: After epilepsy surgery UCLH: A guide for patients considering epilepsy surgery

Continuing medication after surgery does not in itself mean that surgery has failed. Medication may remain part of protection during recovery and observation. Reducing the number of drugs, reducing their burden, and stopping all medication are separate potential decisions. Each requires consideration of postoperative events, including auras, and the consequences of a recurrence.

Patients should know how to report an event and whether it changes a planned review. The date of surgery is a useful reference, but the clinical history after surgery determines what the next stage can reasonably involve.

A 2026 study adds evidence about withdrawal timing

A multicenter observational study published in 2026 included 964 adults who had undergone resective epilepsy surgery and were seizure-free before medication withdrawal. Starting withdrawal within the first two postoperative years was associated with a higher initial relapse risk than later withdrawal. Longer-term outcomes were not substantially associated with starting time. This compared clinical groups; it did not randomly assign every patient to a fixed withdrawal schedule. Ferreira-Atuesta et al.: Timing of antiseizure medication withdrawal after adult epilepsy surgery, multicenter observational study, Neurology 2026

The finding is not an instruction that everyone may stop medication at the two-year anniversary. It also does not guarantee that early withdrawal has no important consequences for a particular person. Children, people with ongoing seizures, and patients treated with stimulation rather than resective surgery cannot simply be assigned the same conclusion.

The discussion needs to include the practical consequences of recurrence: injury, supervision, work responsibilities, and the patient's preferences. A group-level association provides information for that discussion. It does not settle an individual's decision without the rest of the clinical picture.

Two years without seizures can open a discussion, not trigger automatic discontinuation

NICE recommends an individualized assessment of withdrawal risk after two years of seizure freedom. This is not a requirement to discontinue treatment at that point. The AAN withdrawal advisory also addresses recurrence risk, the limits of evidence, and shared decision-making. Cause, seizure type, treatment history, and current circumstances can all influence the decision. NICE NG217: Principles of treatment, safety, monitoring and withdrawal AAN: Antiseizure medication withdrawal in seizure-free patients, practice advisory update, 2021

Ask the clinician to explain the expected benefit of continuing treatment and the possible benefit of reducing it. A lower medication burden may be attractive, but the possible consequences of relapse differ greatly between patients. The timing may matter when someone is starting a demanding job, caring for a dependent person, or has limited access to emergency care.

Some patients may decide to continue the current regimen. Others may consider reducing one drug before discussing complete withdrawal. Either choice deserves a clear explanation and a plan for reassessment rather than an assumption that remaining on medicine represents a personal failure.

A withdrawal plan needs instructions for the unexpected

When supervised withdrawal is appropriate, obtain an understandable written plan. It should identify which medicine changes first, how progress is recorded, when review occurs, and what to do if a possible seizure returns. Withdrawal speed varies between medicines, and some require a particularly gradual reduction. Changing several drugs independently can make both seizure protection and interpretation more difficult.

Confirm whether rescue medication remains necessary and how caregivers should respond to recurrence. Review work, transport, and supervision arrangements with the team according to the patient's circumstances and applicable local requirements. Do not use a general article as permission to drive during a medication change.

If a seizure occurs, follow the agreed response and contact the responsible clinician. Repeatedly increasing and decreasing doses without guidance can create further instability. A prolonged convulsive seizure, repeated events without recovery, or abnormal breathing requires emergency help according to the individual's emergency plan and standard first-aid principles. CDC: First Aid for Seizures NICE NG217: Treating status epilepticus, repeated or cluster seizures, and prolonged seizures

Neurostimulation requires continuing management after implantation

Stimulation treatment generally involves programming and longitudinal assessment. A reduction in seizure frequency reported over years of research cannot be translated into a promise that one patient will become seizure-free within a particular number of months. Nor does it guarantee that medication can be stopped at a preset date. Long-term studies of thalamic and responsive stimulation describe selected populations receiving continuing care. Salanova et al.: SANTE long-term thalamic stimulation study, Epilepsia 2021 Nair et al.: Nine-year prospective brain-responsive neurostimulation outcomes, Neurology 2020

Ask about the planned programming visits, wound checks, device-status assessment, and arrangements for support away from the implanting center. Different devices have different follow-up requirements. The number of inpatient days therefore captures only a small part of the treatment commitment.

For someone considering implantation in China, the ability to obtain suitable device care after returning home should be checked before the procedure. A workable connection between the implanting team and the clinician providing later care is part of the treatment schedule.

Dietary therapy needs an evaluation period and an exit discussion

Before starting a therapeutic ketogenic diet, agree on its aims, how response will be measured, and when the team will reconsider the plan. Seizure changes, nutrition, food tolerance, and the household's ability to carry it out all matter. Recommendations for adults and for children emphasize professional assessment and follow-up rather than one fixed menu for a universal number of months. Cervenka et al.: International recommendations for adults treated with ketogenic diet therapies, 2021 Schoeler et al.: International dietetic best practice for ketogenic dietary therapies in children and young people, 2025

If benefit is insufficient or significant problems arise, the team may adjust the prescription or discuss discontinuation. A family should not persist with unsafe intake merely to complete a promoted treatment course. Equally, a sudden unsupervised change may leave no plan for continuing seizure protection.

The dietitian needs to understand school meals, work, available foods, and caregiver capacity. A schedule that can be maintained in daily life is more useful than a theoretically precise plan that cannot be followed once the patient leaves the specialist center.

Estimate outpatient care, admission, and continuing treatment separately in China

An advance record review can help a Chinese hospital identify the services it may offer. Findings at the in-person assessment can still change the plan. Before committing to transport and accommodation, confirm the purpose of the first appointment, which investigations might require admission, and whether another consultation is needed after results become available.

Ask for a stage-based estimate that can be updated as decisions are made. Confirm language support, caregiver requirements, and the information needed for discharge and onward care. Center information from the China Association Against Epilepsy can help locate services, while appointment availability and specific capabilities need direct confirmation with the hospital. 中国抗癫痫协会官方网站及CAAE癫痫地图入口

Travel preparation should include review by the existing clinical team, continuity of medication supply, and destination medical contacts. Advice for travelers with chronic illness supports preparation tailored to health needs rather than treating travel dates as evidence that treatment can safely be compressed. CDC Yellow Book 2026: Travelers with Chronic Illnesses

Leave room for real-life changes while keeping responsibility clear

Employment, examinations, family care, and visa limits are genuine constraints. Share them early. Some steps may be rearranged, while necessary medical observation cannot always be shortened safely. A new seizure, infection, or adverse reaction may change the return journey and should have a practical contingency plan.

Before leaving China, ask the team to state the next decision explicitly. Will a laboratory result guide an adjustment? Is a longer seizure record needed? Is the next appointment intended to assess postoperative function? Confirm which clinician at home will receive and act on the information.

Nobody can reliably schedule every future treatment decision years in advance. Patients should nevertheless understand why the current stage takes time, what would bring review forward, and who will decide whether the next stage is appropriate.